Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,416.00
Ask: 12,418.00
Change: 44.00 (0.36%)
Spread: 2.00 (0.016%)
Open: 12,330.00
High: 12,450.00
Low: 12,316.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

In Senegal, lack of cold storage limits COVID vaccine options

Mon, 11th Jan 2021 17:09

By Christophe Van Der Perre

DAKAR, Jan 11 (Reuters) - Senegal does not have the capacity
to store COVID-19 vaccines at ultra-low temperatures and would
prefer to receive vials that can be kept for longer under
ordinary refrigeration, the head of the country's vaccination
programme said on Monday.

A lack of cold storage means Senegal would only be able to
keep vaccines developed by AstraZeneca and Oxford
University, by China or Russia in the long term, as they do not
require a deep freeze, Ousseynou Badiane told Reuters.

Those being distributed by Moderna, which require
storage at minus 20 degrees Celsius (-4 F), and Pfizer
and BioNTech, which need to be kept at -70 degrees
Celsius, are less desirable. Senegal could store the Moderna
vaccine for 30 days and the Pfizer one for seven days but after
that they would be spoiled, Badiane added.

The Moderna and Pfizer vaccines "are not our first choice.
Our first choice is the vaccine that fits easily into the system
that exists, that doesn't require major investment," Badiane
told Reuters.

"If the vaccines are not used (in the right time frame) that
would be an enormous waste."

The situation in Senegal highlights the problems that poorer
countries with hot climates face in storing and distributing
vaccines, often in rural areas with unreliable power supplies.

It also shows how far behind some African countries are in
preparing to receive vaccines even as COVID-19 cases surge to
record levels.

Millions have already received inoculations in Western
countries and China, while Senegal is awaiting vaccines through
the World Health Organization-backed global COVAX scheme. This
programme is helping to finance deliveries to 92 developing
nations with limited or no means to buy vaccines on their own.

Senegal is no stranger to vaccination campaigns.

In four walk-in cold rooms in the capital Dakar, authorities
keep thousands of vials of yellow fever and hepatitis B vaccines
at between 2 and 8 degrees Celsius. It has one room that keeps
oral polio vaccines up to minus 25 degrees Celsius.

At the Fann hospital in Dakar, technicians are installing
seven new such rooms. But for now the lack of deep refrigeration
limits the country's options.

"If the option now is to take the (Pfizer or Moderna)
vaccines we... would have to redo all our logistics," Badiane
said.
(Writing by Edward McAllister;
Editing by Hereward Holland and Gareth Jones)

More News
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.